General MedicationsINJECTIONStandard

DOXORUBICIN HYDROCHLORIDE

Standard Dose

50MG/25ML (2MG/ML)

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Prescription

Summary

Approval overview DOXORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 219881 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient DOXORUBICIN HYDROCHLORIDE Form and strength INJECTABLE, LIPOSOMAL;INJECTION - 50MG/25ML (2MG/ML) Sponsor QILU PHARM HAINAN Submission history Latest submission status date: 2026-02-03 00:00:00.

Structured Monograph

Clinical summary

Approval overview DOXORUBICIN HYDROCHLORIDE is listed in Drugs@FDA under application 219881 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DOXORUBICIN HYDROCHLORIDE Form and strength INJECTABLE, LIPOSOMAL;INJECTION - 50MG/25ML (2MG/ML) Sponsor QILU PHARM HAINAN Submission history Latest submission status date: 2026-02-03 00:00:00. Submission type: ORIG.

Monitoring

• Marketing status: Prescription
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.